Phase 2b Data, Phase 3 Trial Design Provide New Insight into Atacicept in IgAN
Data from multiple presentations at ASN Kidney Week 2023 offer insight into the effects of atacicept in patients with IgA nephropathy as well as the design of the phase 3 trial, which is currently enrolling.
United States Richard Lafayette American Society Of Nephrology Kidney Week Stanford Glomerular Disease Center American Society Nephrology Kidney Week
Source: hcplive.com